Reversal of Dabigatran Using Idarucizumab in a Septic Patient with Impaired Kidney Function in Real-Life Practice

Background. Immediate reversal of anticoagulation is essential when facing severe bleeding or emergency surgery. Although idarucizumab is approved for the reversal of dabigatran in many countries, clinical experiences are lacking, particularly in special patient-populations such as sepsis and impair...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauter, Thomas C., Blum, Sina, Nagler, Michael, Schlittler, Fabian L., Ricklin, Meret E., Exadaktylos, Aristomenis K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978858/
https://www.ncbi.nlm.nih.gov/pubmed/27547476
http://dx.doi.org/10.1155/2016/1393057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978858/
https://www.ncbi.nlm.nih.gov/pubmed/27547476
http://dx.doi.org/10.1155/2016/1393057

Ejemplares similares